Dr. Taylor will be in Dallas on Jan 22-23, 2016 for the National Allergan Neurosciences Speaker Training Meeting for Chronic Migraine. He is part of a limited expert national faculty training over 100 headache specialists on how to teach the proper use of Botox in the treatment of chronic migraine to other community neurologists (ie. train the trainers).
Dr. Taylor was a principle investigator in the trial (PREEMPT 2006-2007) that lead to the FDA approval of Botox in migraine in 2010. He lectures and trains doctors from all over the country in the proper use of Botox for conditions including headache, dystonia, and spasticity and has performed this procedure for almost 20 years. He is also the founding president of both the Ohio Neurotoxin Association and the North American Neurotoxin Association (NANA) which are groups dedicated to training doctors on the proper use of botulinum toxin therapy.
Dr. Taylor is board certified in both Neurology and Headache Medicine.